AlphaYouCO
Insider selling
Christopher Ogden sold $5K of CytomX Therapeutics, Inc. (CTMX) stock
Christopher Ogden, Chief Financial Officer of CytomX Therapeutics, Inc. (CTMX), sold 1,624 shares of CTMX stock worth $5K, per an SEC Form 4 filed Jun 17, 2026.
It was an open-market sale.
The trade happened on Jun 15, 2026, 2 days before it was made public.
CTMX has moved -9.2% since the trade date, from $3.04 to $2.76 (Sep 21, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 2 days
- Price since
- -9.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.